Toward Healthy Drug Policy in the United States — The Case of Safehouse
GroupCenter for Public Health Law Research (Temple University Beasley School of Law)
Drug abuse--Government policy
Opioid abuse--United States
Permanent link to this recordhttp://hdl.handle.net/20.500.12613/7412
MetadataShow full item record
DescriptionA new Perspective article in the New England Journal of Medicine examines a recent decision by a Philadelphia judge to reject the argument that an overdose prevention site, called Safehouse, would violate the Controlled Substances Act.The decision signals a move toward an approach to regulating drugs that minimizes both the harms of drugs and the harms caused by regulation itself – worthy goals all around, the authors write.
CitationScott Burris et al., Toward Healthy Drug Policy In The United States — The Case Of Safehouse, 382 New Eng. J. of Med. 4 (2020).
Citation to related workMassachusetts Medical Society
From New England Journal of Medicine, Scott Burris, Evan Anderson, Corey S. Davis, Leo Beletsky, Toward Healthy Drug Policy In The United States — The Case Of Safehouse, 382, 4-5. Copyright © 2020 Massachusetts Medical Society. Reprinted with permission.
Has partNew England Journal of Medicine, 382
ADA complianceFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact firstname.lastname@example.org